CoagulationDisorders near Scranton, PA

Biography: Dr. Melanie Nordlinger, MD is a Hematology Specialist who practices in Willow Grove, PA. She is 53 years old and has been practicing for 25 years. Dr. Melanie Nordlinger, MD is affiliated with Jefferson Abington Hospital.

Biography: Dr. Pearse is a graduate of Dartmouth College and of the combined MD/PhD program at Cornell University Medical College. He completed a Hematology and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center from 1991-1993 and was an Instructor at Memorial Sloan Kettering Cancer Center and Cornell from 1993-1998, participating in the MSKCC autologous bone marrow transplant program and lymphoma/myeloma program. He was Guest Investigator at Rockefeller from 1997-2000, where he did important and creative work on the role of TNF receptor family members in myeloma and bone biology. In 2000, he joined the Division of Hematology and Medical Oncology to join the Multiple Myeloma Program and establish a basic science laboratory.Dr. Pearse has been an attending physician in the Division of Lymphoma/Myeloma Service, Leukemia Service, and Transplant Service since 2000. He is an expert in the clinical management of hematologic malignancies, specifically myeloma, and plays an important clinical role on our autologous and allogeneic bone marrow transplantation unit.Dr. Pearse is nationally recognized for his research on the pathobiology of multiple myeloma.

Care Philosophy: Terenig Terjanian, MD, is a hematologist and medical oncologist at Northwell Health, and an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Growing up in Lebanon, Dr. Terjanians early love for biology and chemistry set him on the path toward medicine. After attending St. Josephs University, he did a residency in pathology at American University of Beirut Medical Center, and one in internal medicine at Staten Island University Hospital. He then did fellowships in hematology and oncology at NYU Grossman School of Medicine and University of Texas MD Anderson Cancer Center. Although he initially specialized in pathology, Dr. Terjanian chose cancer care as a main focus after coming to the United States in 1981. ``The number one thing I want patients to know is that I'll listen to them,`` he says. ``I try to go over every aspect of their disease slowly, explain why we order the tests we do, and have them be completely aware of all the steps,`` he says, adding that he often gives patients his cell number, because he knows concerns can come up anytime. ``I think of what I would want as a patient, and it would be a doctor who really cares.`` Dr. Terjanian is deeply interested in clinical research. He has been the principal investigator on several protocols, including those of the National Surgical Adjuvant Breast and Bowel Project at Staten Island University Hospital, and has published multiple peer-reviewed papers and abstracts and presented at international meetings. He also runs the research committee for medical residents interested in hematology-oncology, and for fellows in that specialty. He's a member of the system-wide Institutional Review Board, a group that ensures clinical trials are done ethically and safely. In addition to participation in weekly tumor board meetings, and frequently providing lectures for interns and residents, Dr. Terjanian still enjoys the chemistry and biology that drew him to medicine from the start, especially since the science in oncology changes so rapidly which leads to improved patient outcomes. ``Every day, there is something new happening in cancer diagnosis and treatment, and it's exciting to see that progress,`` he says. ``Patients are living longer, they're experiencing better quality of life with targeted therapy or immunotherapy. Its immensely satisfying to see how far we've come.``